CBER/CDER Reorganization: Product Transfer Set, Resources Under Review

The CBER/CDER reorganization working group is finalizing a list of approved and investigational products whose reviews would be shifted from the Center for Biologics Evaluation & Research to the Center for Drug Evaluation & Research